Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-26

Clinical Trial Update: A Placebo-Controlled Study of Mirtazapine for PTSD [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting results of a placebo-controlled study of mirtazapine for post-traumatic stress disorder and anxiety symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Anxiety, PTSD | Phase 4 | Status: COMPLETED | Results posted: 2014-11-26